Publication | Closed Access

Long-Term Inhaled Granulocyte Macrophage–Colony-Stimulating Factor in Autoimmune Pulmonary Alveolar Proteinosis: Effectiveness, Safety, and Lowest Effective Dose

Lowest Effective DoseInflammatory Lung DiseaseAutoimmune DiseaseLung InflammationGranulocyteImmunologyPulmonary Alveolar ProteinosisPulmonary PharmacologyPulmonary FibrosisAutoimmunityPulmonary MedicineMedicineMatrikinesPulmonary Disease